These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 654840)

  • 1. Synergistic action of hepatocyte membrane defect and activated complement system in liver cell death--an experimental approach to fulminant hepatic failure.
    Liehr H; Grün M; Seelig HP; Seelig R; Rasenack U
    Acta Hepatogastroenterol (Stuttg); 1978 Apr; 25(2):105-10. PubMed ID: 654840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the pathogenesis of galactosamine hepatitis. Indications of extrahepatocellular mechanisms responsible for liver cell death.
    Liehr H; Grün M; Seelig HP; Seelig R; Reutter W; Heine WD
    Virchows Arch B Cell Pathol; 1978 Feb; 26(4):331-44. PubMed ID: 416592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.
    Masubuchi Y; Horie T
    Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of complement-stimulated hepatic macrophages and neutrophils to endotoxin-induced liver injury in rats.
    Jaeschke H; Farhood A; Smith CW
    Hepatology; 1994 Apr; 19(4):973-9. PubMed ID: 8138272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model.
    Kashani SA; Chang TM
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(3):565-77. PubMed ID: 1760491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model.
    Ho DW; Fan ST; To J; Woo YH; Zhang Z; Lau C; Wong J
    Gut; 2002 Jun; 50(6):869-76. PubMed ID: 12010892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice.
    Kosai K; Matsumoto K; Funakoshi H; Nakamura T
    Hepatology; 1999 Jul; 30(1):151-9. PubMed ID: 10385651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endotoxin-inactivating activity in normal and D-galactosamine induced liver failure rats].
    Taki S; Nakao A
    Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1256-62. PubMed ID: 8272064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactulose--a drug with antiendotoxin effect.
    Liehr H; Englisch G; Rasenack U
    Hepatogastroenterology; 1980 Oct; 27(5):356-60. PubMed ID: 7009359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Toll-like receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fujimoto M; Fukui H
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e494-8. PubMed ID: 18070011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rat model of acute liver necrosis induced by a monoclonal antibody to liver-specific antigen and complement.
    Ikeda T; Kurebayashi Y
    Hepatology; 1991 Jun; 13(6):1152-7. PubMed ID: 1711004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cordyceps sinensis prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Cheng YJ; Cheng SM; Teng YH; Shyu WC; Chen HL; Lee SD
    Am J Chin Med; 2014; 42(2):427-41. PubMed ID: 24707872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines.
    Diaz-Buxo JA; Blumenthal S; Hayes D; Gores P; Gordon B
    Hepatology; 1997 Apr; 25(4):950-7. PubMed ID: 9096603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosamine-induced fulminant liver failure--observation in a porcine model.
    Ho DW; Lam DK; Chen YB; To J; Ng IO; Fan ST
    Asian J Surg; 2002 Jan; 25(1):73-9; discussion 80-1. PubMed ID: 17585450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
    Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
    J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biochemical pathology of liver cell necrosis.
    Farber JL; El-Mofty SK
    Am J Pathol; 1975 Oct; 81(1):237-50. PubMed ID: 1180333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early, reversible plasma membrane injury in galactosamine-induced liver cell death.
    El-Mofty SK; Scrutton MC; Serroni A; Nicolini C; Farber JL
    Am J Pathol; 1975 Jun; 79(3):579-96. PubMed ID: 1137005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat.
    Grün M; Liehr H; Rasenack U
    Acta Hepatogastroenterol (Stuttg); 1977 Apr; 24(2):64-81. PubMed ID: 857560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha.
    Chu CJ; Chen CT; Wang SS; Lee FY; Chang FY; Lin HC; Wu SL; Lu RH; Chan CC; Huang HC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):321-30. PubMed ID: 11534799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.